I rate Tronox as a HOLD due to near-term demand weakness in TiO2, margin pressures, and free cash flow concerns despite long-term tailwinds. Recent earnings disappointed, with negative surprises, ...

Tronox (NYSE:TROX) -0.3% in choppy trading Friday as J.P. Morgan downgraded shares to Neutral from Overweight, saying conditions in the titanium dioxide industry have become more difficult in the near ...

Nanoparticle research presents wide scope for the development of novel solutions in the field of healthcare, cosmetics, optics and electronics. Altering their molecular and atomic states results in ...

Titanium dioxide is crucial in 91,000 drug products for color and stability, despite safety concerns from the European Food Safety Authority. The European Medicines Agency found alternatives to TiO2 ...

Ineos Enterprises will buy a North American titanium dioxide (TiO2) business from Tronox Ltd. for $700 million. The deal includes two plants in Ashtabula, Ohio. Stamford, Conn.-based Tronox needs to ...